Sexually dimorphic responses of the brain norepinephrine system to stress and corticotropin-releasing factor.
Stress-related psychiatric disorders are more prevalent in females than males, and this has been attributed to differences in stress sensitivity. As activation of the locus coeruleus (LC)-norepinephrine (NE) system is an important component of the stress response, this study compared LC responses to stress in female and male rats under different hormonal conditions in the halothane-anesthetized state. The mean basal LC discharge rate was similar between groups. However, the magnitude of LC activation elicited by hypotensive stress was substantially greater in females, regardless of hormonal status. The difference in stress sensitivity could be attributed to the differential postsynaptic sensitivity of LC neurons to corticotropin-releasing factor (CRF), which mediates LC activation by hypotension. CRF was 10-30 times more potent in activating LC neurons in female vs male rats. Interestingly, previous exposure to swim stress differentially regulated LC responses to CRF by sensitizing LC neurons of male, but not female, rats to CRF. The net effect of this was to abolish sex differences in LC sensitivity. Finally, CRF receptor (CRF-R) protein levels in the LC were greater in ovarectomized female vs male rats. This is the first study to demonstrate sex differences in the stress responsiveness of the brain noradrenergic system. Substantial sex differences were apparent in postsynaptic sensitivity to CRF and stress-induced regulation of postsynaptic sensitivity to CRF. These sex differences in the CRF regulation of the LC-NE system translate to a differential response to stress and may play a role in the increased vulnerability of females to stress-related psychiatric disorders.
Curtis
Andre L
AL
Department of Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA 19104, USA. curtisa@email.chop.edu
Bethea
Thelma
T
Valentino
Rita J
RJ
D000818:Animals; D015153:Blotting, Western; D001923:Brain Chemistry / Q000502:physiology*; D003346:Corticotropin-Releasing Hormone / Q000494:pharmacology / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004594:Electrophysiology; D004967:Estrogens / Q000494:pharmacology; D005260:Female; D007022:Hypotension / Q000503:physiopathology; D007150:Immunohistochemistry; D007262:Infusions, Intravenous; D008125:Locus Coeruleus / Q000502:physiology; D008297:Male; D009638:Norepinephrine / Q000502:physiology*; D011374:Progesterone / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D012727:Sex Characteristics; D013315:Stress, Psychological / Q000503:physiopathology*; D013550:Swimming / Q000523:psychology
D004967:Estrogens; D011374:Progesterone; D003346:Corticotropin-Releasing Hormone; D009638:Norepinephrine